Xiamen Kingdomway Group Overview

  • Founded
  • 1997
  • Status
  • Public
  • Employees
  • 2,003
  • Stock Symbol
  • 002626
Stock Symbol
  • Investments
  • 9
  • Share Price
  • $4.43
  • (As of Tuesday Closing)

Xiamen Kingdomway Group General Information


Xiamen Kingdomway Group Co is a China-based company mainly engaged in the development and innovation of nutrition enhancer and bio-medical products. The company's main products are Coenzyme Q10, microalgae DHA, plant ARA, vitamin A, and vitamin D3.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • No. 299, West Yangguang Road
  • Xinyang Industrial Area, Haicang Investment Zone
  • Xiamen, 361022
  • China
+86 0592 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xiamen Kingdomway Group Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.43 $4.59 $4.41 - $7.95 $2.73B 616M 4.04M $0.21

Xiamen Kingdomway Group Financials Summary

In Thousands,
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 3,092,142 3,280,375 1,844,276 1,179,554
Revenue 558,658 507,252 461,932 434,241
EBITDA 147,327 184,685 111,558 143,568
Net Income 127,412 138,842 65,229 103,888
Total Assets 873,493 788,678 671,528 666,809
Total Debt 194,784 149,140 175,817 166,618
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xiamen Kingdomway Group Patents

Xiamen Kingdomway Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200354757-A1 Methods for a controlled coenzyme q10 fermentation production process Pending 08-May-2019 00000000
US-20200087235-A1 Systems and methods for producing coenzyme q10 Pending 06-Aug-2018 000000000
US-20180353444-A1 Composition for preventing and/or treating cardiovascular and cerebrovascular diseases Granted 25-Aug-2015 0000000000
US-10857108-B2 Composition for preventing and/or treating cardiovascular and cerebrovascular diseases Active 25-Aug-2015 0000000000 00
US-20150361461-A1 Method for producing dha through solid culture and liquid fermentation of schizochytrium Granted 31-Dec-2012 C12P7/6427 0
To view Xiamen Kingdomway Group’s complete patent history, request access »

Xiamen Kingdomway Group Executive Team (2)

Name Title Board Seat Contact Info
Yan Hong Chief Financial Officer & Vice President
Ma Guoqing Deputy General Manager
To view Xiamen Kingdomway Group’s complete executive team members history, request access »

Xiamen Kingdomway Group Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xiamen Kingdomway Group Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 19-Aug-2021 00000 0000 Drug Discovery
000 0000 01-Jul-2020 00000 0000 Educational and Training Services (B2C)
0000000 18-May-2018 0000000000 0000 Beverages
00000000 01-Aug-2016 0000000000 Food Products
Doctor's Best 15-Jun-2016 Secondary Transaction - Private Food Products
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Xiamen Kingdomway Group Subsidiaries (3)

Company Name Industry Location Founded
ProSupps Food Products Plano, TX 2011
0000000 Beverages Woodinville, WA 0000
000000'0 0000 Food Products Irvine, CA 0000
To view Xiamen Kingdomway Group’s complete subsidiaries history, request access »